TrialCardiovascular drugs and therapy2011

Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.

Robert S Rosenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.